Disturbances of selected plasma proteins in hyperdynamic septic shock.
This study was performed on patients (n = 18) suffering from strictly defined hyperdynamic septic shock. Plasma factors (C-reactive protein, acid alpha 1-glycoprotein, fibrinogen, fibrinopeptide A, fibrinogen-fibrin split products, factor XIII, antithrombin III, complement factors C3 and C4, inter-alpha-trypsin-inhibitor and alpha 2-macroglobulin) measured during hyperdynamic septic shock were highly abnormal. The activation and consumption of clotting, fibrinolytic and complement factors due to system-specific proteinases (such as thrombokinase or plasminogen activators) seemed to be intensified by the nonspecific proteolytic activity of granulocytic proteinases probably released by the action of endotoxins. Possible therapeutic measures to maintain the endogeneous defence mechanism against enhanced proteolysis during septic shock are discussed.
D000510:Alpha-Globulins / Q000032:analysis / Q000097:blood; D000990:Antithrombin III / Q000032:analysis; D001779:Blood Coagulation Factors / Q000032:analysis; D001798:Blood Proteins / Q000378:metabolism*; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D005337:Fibrin / Q000032:analysis; D006801:Humans; D007962:Leukocytes / Q000276:immunology; D007964:Leukocytosis; D007970:Leukopenia / Q000209:etiology; D008297:Male; D011446:Prospective Studies; D011480:Protease Inhibitors / Q000097:blood*; D012772:Shock, Septic / Q000097:blood / Q000503:physiopathology; D014361:Trypsin Inhibitors / Q000097:blood; D000511:alpha-Macroglobulins / Q000032:analysis
D000510:Alpha-Globulins; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D000511:alpha-Macroglobulins; C011877:inter-alpha-inhibitor; D000990:Antithrombin III; D005337:Fibrin; D003165:Complement System Proteins